Elevated liver enzymes often present a diagnostic challenge to clinicians due to their diverse etiologies. A comprehensive, systematic approach is crucial for accurate diagnosis and management.
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are the most commonly evaluated liver enzymes. Elevation of these enzymes indicates hepatocyte injury but not the cause. Thus, understanding the pattern of liver enzyme elevation is key to narrow down the differential diagnoses.
Common causes include alcohol consumption, viral hepatitis, non-alcoholic fatty liver disease (NAFLD), and drug-induced liver injury. Less common causes include autoimmune hepatitis, hemochromatosis, and Wilson's disease. It's important to consider these possibilities, especially in the absence of common risk factors.
A comprehensive history and physical examination, combined with appropriate investigations, are the cornerstone of the diagnostic approach. Investigations should include hepatitis serology, autoantibodies, iron studies, and ceruloplasmin levels. In some cases, imaging studies or liver biopsy may be required.
Management should be tailored based on the underlying cause. For example, lifestyle modifications and weight loss are recommended for NAFLD, while antiviral therapy is the mainstay of treatment for viral hepatitis. In cases of drug-induced liver injury, discontinuation of the offending agent is crucial.
Diagnosing and managing elevated liver enzymes require a thorough understanding of the various etiologies and a systematic approach. By maintaining high clinical suspicion and utilizing appropriate investigations, clinicians can accurately diagnose and effectively manage patients with elevated liver enzymes, ultimately improving patient outcomes.
1.
Lung nodules seen in a high percentage of non-smokers
2.
Providing essential cancer care to rural communities
3.
Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women
4.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
5.
De-escalation Misses the Mark in Inflammatory Breast Cancer
1.
Adaptive Cell Therapies for Solid Tumors
2.
Mast Cell-Tumor Cell Interactions in OSCC: Genetic and microRNA Insights
3.
The Mysterious World of Petechiae: Exploring Causes and Treatments
4.
The Surprising Role of Magnesium in Digestion, Sleep and Mental Health
5.
Tumor Microenvironment Targeting: Mechanisms, Clinical Implications, and Therapeutic Advances
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
3.
Thromboprophylaxis In Medical Settings- An Update
4.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation